ENTITY

Theseus Pharmaceuticals (THRX US)

Health Care • United States

Theseus Pharmaceuticals, Inc. operates as a biotech company. The Company develops oncology therapies to address treatment-resistant cancer mutations. Theseus Pharmaceuticals serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00